175 related articles for article (PubMed ID: 38424116)
1. Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms.
Sayed GI; Solyman M; El Gedawy G; Moemen YS; Aboul-Ella H; Hassanien AE
Sci Rep; 2024 Feb; 14(1):4989. PubMed ID: 38424116
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
3. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians.
Youssef SS; Elfiky A; Nabeel MM; Shousha HI; Elbaz T; Omran D; Marie MS; Elzahry MA; Abul-Fotouh A; Hashem A; Guda MF; Abdelaziz AO
World J Hepatol; 2022 Aug; 14(8):1562-1575. PubMed ID: 36157872
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
Yu B; Zhou S; Liang H; Ye Q; Wang Y
Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217
[TBL] [Abstract][Full Text] [Related]
5. Novel miRNA signature for predicting the stage of hepatocellular carcinoma.
Yerukala Sathipati S; Ho SY
Sci Rep; 2020 Sep; 10(1):14452. PubMed ID: 32879391
[TBL] [Abstract][Full Text] [Related]
6. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
7. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
[TBL] [Abstract][Full Text] [Related]
9. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.
Yosry A; Zayed N; Dawood RM; Ibrahim MK; Elsharkawy M; Ekladious SM; Khairy A; Elsharkawy A; Khairy M; Abdel Alem S; Bader El Din NG; El Awady MK; Abdellatif Z
Lab Med; 2022 Sep; 53(5):523-529. PubMed ID: 35731638
[TBL] [Abstract][Full Text] [Related]
10. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
13. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
14. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
[TBL] [Abstract][Full Text] [Related]
16. Value of Serum miRNA-96-5p and miRNA-99a-5p as Diagnostic Biomarkers for Hepatocellular Carcinoma.
Gharib AF; Eed EM; Khalifa AS; Raafat N; Shehab-Eldeen S; Alwakeel HR; Darwiesh E; Essa A
Int J Gen Med; 2022; 15():2427-2436. PubMed ID: 35264879
[TBL] [Abstract][Full Text] [Related]
17. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning.
Gupta R; Kleinjans J; Caiment F
BMC Cancer; 2021 Aug; 21(1):962. PubMed ID: 34445986
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.
Chen W; Wang H; Li T; Liu T; Yang W; Jin A; Ding L; Zhang C; Pan B; Guo W; Wang B
BMC Med Genomics; 2022 Feb; 15(1):34. PubMed ID: 35197055
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
